Europe & Central Asia (IDA & IBRD countries) vs Sweden: Domestic general government health expenditure per capita, PPP

Europe & Central Asia (IDA & IBRD countries)
1,588 current international $
in 2023
Sweden
6,467 current international $
in 2023
Europe & Central Asia (IDA & IBRD countries) rank
9th
Sweden rank
7th

Domestic general government health expenditure per capita, PPP over time

  • Europe & Central Asia (IDA & IBRD countries)
  • Sweden
02.0k4.0k6.0k200020112023

How they compare

Sweden currently reports 6,467 current international $ against 1,588 current international $ in Europe & Central Asia (IDA & IBRD countries), a difference of 4,879 current international $.

That makes Sweden's figure about 4.1 times Europe & Central Asia (IDA & IBRD countries)'s.

Across all 24 years both countries report, Sweden has been ahead every year.

Europe & Central Asia (IDA & IBRD countries) ranks 9th and Sweden ranks 7th of 47 groups.

Sweden has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Europe & Central Asia (IDA & IBRD countries) Sweden Difference Ahead
2000s 358.66 current international $ 2,360 current international $ 2,001 current international $ Sweden
2010s 681.4 current international $ 4,391 current international $ 3,710 current international $ Sweden
2020s 1,369 current international $ 6,101 current international $ 4,732 current international $ Sweden

Averages of every year both report within each decade.

Frequently asked questions

Which has higher domestic general government health expenditure per capita, ppp, Europe & Central Asia (IDA & IBRD countries) or Sweden?
Sweden, at 6,467 current international $ against 1,588 current international $ in Europe & Central Asia (IDA & IBRD countries) as of 2023.
What is the difference in domestic general government health expenditure per capita, ppp between Europe & Central Asia (IDA & IBRD countries) and Sweden?
4,879 current international $, with Sweden ahead.
How many years of comparable data are there for Europe & Central Asia (IDA & IBRD countries) and Sweden?
24 years are reported by both, from 2000 to 2023.
How do Europe & Central Asia (IDA & IBRD countries) and Sweden rank globally for domestic general government health expenditure per capita, ppp?
Europe & Central Asia (IDA & IBRD countries) ranks 9th and Sweden ranks 7th of 47 groups.
Where does this data come from?
Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Domestic general government health expenditure per capita, PPP (current international $). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia (IDA & IBRD countries) vs Sweden: Domestic general government health expenditure per capita, PPP. Statizoid, drawing on Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/domestic-general-government-health-expenditure-per-capita-ppp-current-international/europe-and-central-asia-ida-and-ibrd-countries/sweden/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/domestic-general-government-health-expenditure-per-capita-ppp-current-international/europe-and-central-asia-ida-and-ibrd-countries/sweden/">Europe & Central Asia (IDA & IBRD countries) vs Sweden: Domestic general government health expenditure per capita, PPP</a> — Statizoid

About this data

Indicator
Domestic general government health expenditure per capita, PPP (current international $)
Unit
current international $
Source
Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
240 places, 5,674 data points, 2000–2024
Last refreshed

Public expenditure on health from domestic sources per capita expressed in international dollars at purchasing power parity.